Epstein-Barr virus and its association with disease - a review of relevance to general practice.
Fugl A, Andersen CL.
BMC Fam Pract. 2019 May 14;20(1):62. doi: 10.1186/s12875-019-0954-3.
Editorial: testing for Epstein-Barr virus and treating autoimmune hepatitis-still a long way to go!
Bolia R, Srivastava A.
Aliment Pharmacol Ther. 2022 Feb;55(3):364-365. doi: 10.1111/apt.16751.
Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Authors' reply.
Nayagam JS, Heneghan MA, Samyn M, Joshi D.
Aliment Pharmacol Ther. 2022 Feb;55(3):366-367. doi: 10.1111/apt.16759.
Epstein-Barr Virus-Associated Acute Dacryocystic Retention.
Bothra N, Ali MJ.
Ocul Immunol Inflamm. 2024 Jan;32(1):131-133. doi: 10.1080/09273948.2022.2159448. Epub 2023 Jan 13.
Epstein Barr virus hepatitis.
Kofteridis DP, Koulentaki M, Valachis A, Christofaki M, Mazokopakis E, Papazoglou G, Samonis G.
Eur J Intern Med. 2011 Feb;22(1):73-6. doi: 10.1016/j.ejim.2010.07.016. Epub 2010 Aug 19.
Epstein-Barr virus-associated cholestatic hepatitis.
Salva I, Silva IV, Cunha F.
BMJ Case Rep. 2013 Dec 16;2013:bcr2013202213. doi: 10.1136/bcr-2013-202213.
Epstein-Barr Virus Coinfection in COVID-19.
Nadeem A, Suresh K, Awais H, Waseem S.
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211040626. doi: 10.1177/23247096211040626.
Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult.
Hinedi TB, Koff RS.
Dig Dis Sci. 2003 Mar;48(3):539-41. doi: 10.1023/a:1022592801060.
Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes.
Leonardsson H, Hreinsson JP, Löve A, Björnsson ES.
Scand J Gastroenterol. 2017 Aug;52(8):893-897. doi: 10.1080/00365521.2017.1319972. Epub 2017 Apr 27.
Epstein-Barr virus reactivation.
Ternák G.
Lancet Infect Dis. 2003 May;3(5):271. doi: 10.1016/s1473-3099(03)00603-0.
